Navigation Links
Actavis Extends Portfolio With Four New Products in the U.S.
Date:2/27/2008

MORRISTOWN, N.J., Feb. 27 /PRNewswire/ -- Actavis Group, the international generic pharmaceuticals company, has received approval on four new products from the U.S. Food & Drug Administration.

The four products include:

Phendimetrazine tartrate tablets, 35mg: the generic equivalent of Bontril(R) tablets by Valeant Pharmaceuticals, are indicated in the adjunct management of weight loss. Annual sales of Phendimetrazine tartrate tablets had annual sales of US$3.1 million for the 12 months ending December 2007 according to IMS Health data.

Buspirone tablets, 30mg: the generic equivalent of Bristol Myers Squibb's Buspar(R). Buspirone tablets, used in the treatment of anxiety disorders, had annual sales of US$15.4 million for the 12 months ending December 2007 according to IMS Health data.

Baclofen tablets: the generic equivalent of Lioresal(R) tablets by Novartis, will be available in 10mg and 20mg strengths. Baclofen tablets are used to relax muscles and relieve pain and discomfort associated with certain nerve disorders.

Benztropine Mesylate Tablets, 0.5mg, 1mg, 2mg: are the generic equivalent to Cogentin(R). Benztropine mesylate is an antidrykinetic, which reduces the symptoms of Parkinson's disease by improving muscle control and reducing stiffness. Annual sales of Benztropine mesylate were US$12.8 million for the 12 months ending December 2007 according to IMS Health data.

Commenting on the new approvals, Terry Fullem, Vice President of Marketing and Portfolio in the U.S. said:

"These approvals signify our commitment to provide our customers with a broad and expanding pipeline. We launched 19 products in the United States in 2007 and plan to increase that number in 2008. Actavis currently has over 70 pending applications at the FDA, including a growing list of first-to-file generic products. This momentum in our development pipeline will ensure that we continue to be on the forefront of bringing new generic pro
'/>"/>

SOURCE Actavis Group
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Actavis Confirms its Patent Challenge of Kings Avinza(R)
2. Actavis Launches Amlodipine Tablets in the U.S.
3. Actavis Launches Carvedilol Tablets in the U.S.
4. EMC Extends Innovation for VMware environments
5. The Centers for Medicare & Medicaid Services Extends LifeMasters Demonstration Project in Florida
6. BioMed Realty Trust Joint Venture Enters Into New $245 Million Construction Loan and Extends Term of Existing Loan Facility
7. Office of Administration Extends Retired State Employees Health Benefits Enrollment Period to March 21
8. Compuware Covisint Extends Commitment to Healthcare Industry with Acquisition of Hilgraeve, Inc.
9. A Little Regular Exercise Extends Mens Lives
10. Advanced Home Care Extends Its Use of Authentidates Inscrybe(TM) Healthcare Platform
11. OSHA Extends Comment Period for Lookback Review of Methylene Chloride Standard
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...CAGO Results of a 10-year study published in the ...icine found that magnesium sulfate administered t...duced the risk of cerebral palsy by 50 percent. Th...e (BEAM) trial was conducted in 18 centers in the ...first prenatal intervention ever found to reduce t...
(Date:8/29/2008)... Allsup explains financial imp...ing calculators available to people with disabilit...Vocus) August 29, 2008 -- Deciding how to move for...s a personal matter, but it,s important that indiv...financial options, according to http://www.allsup...
(Date:8/28/2008)...ight stays with person with dementia led to daytim...THURSDAY, Aug. 28 (HealthDay News) -- Older adults...night for someone with dementia have significantly...hers say. , The study compared 31 caregivers a...ept about 33 minutes less per night than non-careg...
(Date:8/28/2008)...OUNTAIN VIEW, Calif., Aug. 28 /PRNewswire/ -- The ... Year Award is presented to Redsense,Medical in re...lood loss,detecting device. "Redsense detects the ... lives of many patients"., The device consists of...ted to the alarm using fibre optic technology that...
Breaking Medicine News(10 mins):Health News:National study shows magensium sulfate reduces risk of cerebral palsy in premature births 2Health News:Social Security Disability Can Be Key to Financial Future 2Health News:Social Security Disability Can Be Key to Financial Future 3Health News:Social Security Disability Can Be Key to Financial Future 4Health News:Social Security Disability Can Be Key to Financial Future 5Health News:Social Security Disability Can Be Key to Financial Future 6Health News:Older Caregivers Prone to Worse Sleep Patterns 2Health News:Frost & Sullivan Honours Redsense Medical With the 2008 European Hemodialysis Emerging Company of the Year Award 2Health News:Frost & Sullivan Honours Redsense Medical With the 2008 European Hemodialysis Emerging Company of the Year Award 3
...The Indian Medical Association (IMA) has accused U...sthesis in India at cheaper prices . "It is shocki... prosthesis in India," IMA president Ajay Kumar sa...d that US companies are selling knee and hip prost...
...Japan is a step closer to having an ideal worker w...y floors as a company unveiled a next-generation h...t Mk-II, a 160-centimetre-tall (five feet, four in...d on a slippery floor scattered with sand and held...
...According to a RAND Corporation study issued today...hronically ill children when given greater access ...ir jobs. We found that having the time and finan...ly important for parents who have children with se...
...Researchers at Washington University School of Med...rferes with ligament healing. Studying mice with...ette smoking impairs the recruitment of cells to t... ligament-repair surgery. They reported their find...
Other Medicine News:Health News:Employer Leave Helps the Parents of Chronically Ill Kids 2Health News:Employer Leave Helps the Parents of Chronically Ill Kids 3Health News:Cigarette Smoking Delays Ligament Healing 2Health News:Cigarette Smoking Delays Ligament Healing 3
(Date:8/26/2008)...mpany to present data from landmark SYNTAX clinica...Call/ -- Boston Scientific,Corporation (NYSE: BSX...ajor,events and press announcements at the Europea...from August 30 to September 3 in Munich, Germany.,... the SYNTAX trial,which compares percutaneous cor...
(Date:8/26/2008)...finds most patients can drive safely six weeks fol...6 /PRNewswire-USNewswire/ -- Six weeks following,b...ow that they are able to,get back behind the wheel...008 issue of The Journal of Bone and Joint Surgery...y brake time response in patients who underwent a,...
(Date:8/26/2008)...PARK, Calif., Aug. 26 /- XT...e positive one-year follow-up data,from the CUSTOM...f the,peer-reviewed journal, EuroIntervention. The...la, M.D., of University Medical Center Utrecht, Ut...Investigators from 13 clinical,sites across Europe...
(Date:8/25/2008)...covers Stem Cells Found in Menstrual Blood May Off...for Time-Pressed Women, OLDSMAR, Fla., Aug. 25 /P...t most women would agree that there never seems to...oman spends on doing something just,for herself us...in others.,This reality has led many women in need...
Breaking Medicine Technology:Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008 2Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008 3Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008 4Braking After Bunion Surgery 2Braking After Bunion Surgery 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 2XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 4Going Beyond 'Spa Day': Giving Women the Opportunity to Do Something Proactive Which May Lead to Long Term Health Benefits 2HIV isolate from Kenya provides clues for vaccine design 1762 1Language centers revealed brain surgery refined with new mapping 8983 1Language centers revealed brain surgery refined with new mapping 8983 2Language centers revealed brain surgery refined with new mapping 8983 3Protein a possible key to allergy and asthma control 8980 1Protein a possible key to allergy and asthma control 8980 2Protein a possible key to allergy and asthma control 8980 3New strategies work to put cancer on the firing line 8977 1New strategies work to put cancer on the firing line 8977 2New strategies work to put cancer on the firing line 8977 3
...un 21, 2007 - Answerthink, Inc. (NASDAQ:,ANSR) ann...ce with,LORENZ Life Sciences Group for the distrib...think and LORENZ Life Sciences Group will,serve mi...ssions,management solutions into Answerthink,s Lif...erthink,s pre-configured EzLifeSciences solutions ...
...-Jun 20, 2007 - Senator Obama today,released the f...,veto of Stem Cell Bill:, "By vetoing funding for ...ferring the hopes of millions of Americans who do,...t may save or,extend their lives. The promise that... ideology, it is the judgment of science, and we,d...
Other Medicine Technology:Answerthink and LORENZ Life Sciences Group Announce Strategic,Alliance for the SAP Life Science Industry 2Answerthink and LORENZ Life Sciences Group Announce Strategic,Alliance for the SAP Life Science Industry 3
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
Medicine Products: